About SH3 and cysteine-rich domain-containing protein 3
SH3 and cysteine-rich domain-containing protein 3 (STAC3) is a protein
from Homo sapiens identified by UniProt accession
Q96MF2, 364 residues long.
MolForge cross-references it against 0 known binders and
244 disease associations.
Target properties
| Protein name | SH3 and cysteine-rich domain-containing protein 3 |
| UniProt accession | Q96MF2 |
| Gene | STAC3 |
| Organism | Homo sapiens |
| Length | 364 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (244)
Diseases linked to this target (Open Targets).
- Bailey-Bloch congenital myopathy · score 0.78
- Native American myopathy · score 0.72
- genetic disorder · score 0.41
- congenital myopathy · score 0.27
- reticulocyte count · score 0.10
- IGF-1 measurement · score 0.08
- low density lipoprotein cholesterol measurement · score 0.07
- body mass index · score 0.07
- urate measurement · score 0.07
- creatinine measurement · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96MF2-F1 | alphafold | PREDICTED | 69.28 | — |
Amino-acid sequence (364 residues)
MTEKEVLESP KPSFPAETRQ SGLQRLKQLL RKGSTGTKEM ELPPEPQANG EAVGAGGGPI YYIYEEEEEE EEEEEEPPPE PPKLVNDKPH KFKDHFFKKP KFCDVCARMI VLNNKFGLRC KNCKTNIHEH CQSYVEMQRC FGKIPPGFHR AYSSPLYSNQ QYACVKDLSA ANRNDPVFET LRTGVIMANK ERKKGQADKK NPVAAMMEEE PESARPEEGK PQDGNPEGDK KAEKKTPDDK HKQPGFQQSH YFVALYRFKA LEKDDLDFPP GEKITVIDDS NEEWWRGKIG EKVGFFPPNF IIRVRAGERV HRVTRSFVGN REIGQITLKK DQIVVQKGDE AGGYVKVYTG RKVGLFPTDF LEEI
Explore SH3 and cysteine-rich domain-containing protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets